畅脉乐通过调控PPAR信号通路对动脉粥样硬化大鼠巨噬细胞自噬、血管内皮功能及动脉斑块稳定性相关蛋白影响
Changmaile Affects Macrophage Autophagy, Vascular Endothelial Function and Arterial Plaque Stability-Related Proteins in Atherosclerotic Rats by Regulating the PPAR Signaling Pathway
DOI: 10.12677/ACM.2023.13102333, PDF,    科研立项经费支持
作者: 黄松雄*, 刘巧婷, 李 志, 吴帮发, 何洪金:福建中医药大学附属第二人民医院健康管理中心,福建 福州;张玉琴#:福建中医药大学附属第二人民医院影像科,福建 福州
关键词: 畅脉乐动脉粥样硬化过氧化物酶体增殖物激活受体细胞自噬血管内皮斑块稳定性Changmaile Atherosclerosis Peroxisome Proliferator-Activated Receptor Autophagy Vascular Endothelium Plaque Stability
摘要: 目的:通过观察畅脉乐对过氧化物酶体增殖物激活受体(PPAR)信号通路的调控,研究畅脉乐对动脉粥样硬化大鼠巨噬细胞自噬、血管内皮功能及动脉斑块稳定性相关蛋白的影响。方法:将30只大鼠随机分为对照组(n = 10)、模型组(n = 10)及畅脉乐组(n = 10);除对照组外,模型组及畅脉乐组大鼠均以高脂饮食为诱变剂建立动脉粥样硬化模型。畅脉乐组按5 mg/(kg•d)剂量服用畅脉乐胶囊,对照组和模型组予以相应饲料喂养,干预周期均为8周。8周后采血和采集血管组织,采用透射电镜观察巨噬细胞中自噬小体数量,蛋白免疫印迹法检测巨噬细胞中酶联相关轻链蛋白3 (LC3)、选择性自噬接头蛋白p62 (p62)的表达水平,免疫荧光吸附法检测大鼠血清血管性血友病因子(vWF)、一氧化氮(NO)、内皮素-1 (ET-1)、一氧化氮合酶(eNOS)含量,Western blot法检测动脉斑块稳定性相关蛋白[基质金属蛋白酶(MMP)-2、MMP-9、MMP抑制剂(TIMP)-1]及PPAR信号通路[PPARγ/肝脏X受体α/ATP结合盒转运体G1 (PPARγ/LXRα/ABCG1)]相关蛋白表达水平,RT-PCR测定细胞内PPARγ、LXRα、ABCG1的mRNA水平。结果:与对照组比较,模型组大鼠自噬小体数量有所减少,LC3II/I表达水平明显下降,p62表达水平明显上升(P < 0.05);MMP-2、MMP-9表达水平明显上升,TIMP-1表达水平明显下降(P < 0.05);PPARγ、LXRα、ABCG1蛋白及mRNA表达水平明显下降(P < 0.05)。与模型组比较,畅脉乐组大鼠自噬小体数量增加,LC3II/I表达水平明显上升,p62表达水平明显下降(P < 0.05);MMP-2、MMP-9表达水平明显下降,TIMP-1表达水平明显上升(P < 0.05);PPARγ、LXRα、ABCG1蛋白及mRNA表达水平明显上升(P < 0.05)。结论:畅脉乐能够通过调控PPAR信号通路,上调动脉粥样硬化大鼠巨噬细胞自噬水平,改善血管内皮功能,提高动脉斑块的稳定性,进而起到抗脉粥样硬化的作用。
Abstract: Purpose: By observing the regulation of Changmaile on the peroxisome proliferator-activated re-ceptor (PPAR) signaling pathway, study the effect of Changmaile on macrophage autophagy, vascu-lar endothelial function and arterial plaque stability-related proteins in atherosclerotic rats. Meth-ods: 30 rats were randomly divided into control group (n = 10), model group (n = 10) and Changmaile group (n = 10); except for the control group, rats in the model group and Changmaile group Atherosclerosis models were established using high-fat diet as mutagen. The Changmaile group took Changmaile capsules at a dose of 5 mg/(kg•d), and the control group and model group were fed corresponding feeds. The intervention period was 8 weeks. After 8 weeks, blood and vas-cular tissues were collected. Transmission electron microscopy was used to observe the number of autophagosomes in macrophages. Western blotting was used to detect enzyme-linked light chain protein 3 (LC3) and selective autophagy adapter protein p62 expression level in macrophages. Im-munofluorescence adsorption method was used to detect rat serum von Willebrand factor (vWF), nitric oxide (NO), endothelin-1 (ET-1), nitric oxide synthase (eNOS) content, Western blot method was used to detect arterial plaque stability-related proteins [matrix metalloproteinase (MMP)-2, MMP-9, MMP inhibitor (TIMP)-1] and PPAR signaling pathway [PPARγ/liver X receptor α/ATP Binding cassette transporter G1 (PPARγ/LXRα/ABCG1)] related protein expression levels, and RT-PCR measured the intracellular mRNA levels of PPARγ, LXRα, and ABCG1. Results: Compared with the control group, the number of autophagosomes in the model group decreased, the expres-sion level of LC3II/I decreased significantly, and the expression level of p62 increased significantly (P < 0.05); the expression levels of MMP-2 and MMP-9 increased significantly. The expression level of TIMP-1 decreased significantly (P < 0.05); the expression levels of PPARγ, LXRα, ABCG1 protein and mRNA decreased significantly (P < 0.05). Compared with the model group, the number of au-tophagosomes in the Changmaile group increased, the expression level of LC3II/I increased signifi-cantly, and the expression level of p62 decreased significantly (P < 0.05); the expression levels of MMP-2 and MMP-9 decreased significantly, and the expression level of TIMP-1 expression level in-creased significantly (P < 0.05); PPARγ, LXRα, ABCG1 protein and mRNA expression levels in-creased significantly (P < 0.05). Conclusion: Changmaile can upregulate the autophagy level of mac-rophages in atherosclerotic rats, improve vascular endothelial function, increase the stability of ar-terial plaques, and play an anti-atherosclerotic role by regulating the PPAR signaling pathway.
文章引用:黄松雄, 张玉琴, 刘巧婷, 李志, 吴帮发, 何洪金. 畅脉乐通过调控PPAR信号通路对动脉粥样硬化大鼠巨噬细胞自噬、血管内皮功能及动脉斑块稳定性相关蛋白影响[J]. 临床医学进展, 2023, 13(10): 16670-16677. https://doi.org/10.12677/ACM.2023.13102333

参考文献

[1] 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6): 553-578.
[2] Hu, H.J., Wang, X.H., Zhang, T.Q., et al. (2022) PLK1 Promotes Cholesterol Efflux and Alleviates Atherosclerosis by up-Regulating ABCA1 and ABCG1 Expression via the AMPK/PPARγ/LXRα Pathway. Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, 1867, Article ID: 159221. [Google Scholar] [CrossRef] [PubMed]
[3] Wagner, N. and Wagner, K.D. (2023) Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease. Inter-national Journal of Molecular Sciences, 24, Article 2345. [Google Scholar] [CrossRef] [PubMed]
[4] 陈成, 张旺生, 陈铃, 等. 畅脉乐Ⅱ胶囊对血瘀型颈动脉粥样硬化患者CRP、IL-6及血栓相关参数的影响[J]. 山西中医, 2022, 38(5): 12-15.
[5] 赵晶, 秦合伟, 李彦杰, 等. 血管软化丸调控PI3K/Akt/mTOR通路影响细胞自噬及抗动脉粥样硬化的作用机制研究[J]. 中华中医药学刊, 2020, 38(1): 65-69, 268-270.
[6] 翁一玲, 李煌, 卓辰茜, 等. 基于UPLC-QE-MS技术的畅脉乐胶囊化学成分分析及其抗脑血栓的网络药理学研究[J]. 中国现代药物应用, 2022, 16(21): 173-178.
[7] Zhang, H., Ge, S., Ni, B., et al. (2021) Augmenting ATG14 Alleviates Atherosclerosis and In-hibits Inflammation via Promotion of Autophagosome-Lysosome Fusion in Macrophages. Autophagy, 17, 4218-4230. [Google Scholar] [CrossRef] [PubMed]
[8] 曹乾. 在ApoE-/-小鼠中青蒿素通过AMPK/mTOR/ULK1促进巨噬细胞自噬减轻动脉粥样硬化机制研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2021.
[9] 鲍友利, 曹寅, 吴鸿飞. “瓜蒌-薤白”药对诱导自噬抑制NLRP3炎症小体激活减轻RAW264.7巨噬细胞炎症反应[J]. 中国中药杂志, 2023, 48(10): 2820-2828.
[10] Alexander, Y., Osto, E., Schmidt-Trucksäss, A., et al. (2021) Endothelial Function in Cardiovascular Medicine: A Consensus Paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Micro-circulation, and Thrombosis. Cardiovascular Research, 117, 29-42. [Google Scholar] [CrossRef] [PubMed]
[11] 曹程浩, 董晓瑞, 黄斌. 丹参饮合二陈汤加减对颈动脉粥样硬化血管内膜损伤的保护作用[J]. 中国实验方剂学杂志, 2021, 27(7): 86-91.
[12] Zhang, F., Guo, X., Xia, Y. and Mao, L. (2021) An Update on the Phenotypic Switching of Vascular Smooth Muscle Cells in the Pathogenesis of Atherosclerosis. Cellular and Molecular Life Sciences, 79, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[13] Munteanu, C. (2023) Hydrogen Sulfide and Oxygen Homeosta-sis in Atherosclerosis: A Systematic Review from Molecular Biology to Therapeutic Perspectives. International Journal of Molecular Sciences, 24, Article 8376. [Google Scholar] [CrossRef] [PubMed]
[14] 杨天睿, 苗云波, 段靳岚, 等. 血液生化指标与颈动脉粥样硬化斑块稳定性的相关性研究[J]. 中华老年心脑血管病杂志, 2022, 24(3): 237-239.
[15] 杨雅雯, 夏敏, 吴芬, 等. Rho相关卷曲螺旋蛋白激酶1在动脉粥样硬化血管壁中的表达及其与基质金属蛋白酶2及转化生长因子1的相关性[J]. 中华老年多器官疾病杂志, 2023, 22(1): 53-58.
[16] Nasiri-Ansari, N., Spilioti, E., Kyrou, I., et al. (2022) Estro-gen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Athero-sclerotic Plaque Vulnerability. International Journal of Molecular Sciences, 23, Article 10960. [Google Scholar] [CrossRef] [PubMed]
[17] 王建民, 孟蓓, 王胜利, 等. 通窍活血汤对动脉粥样硬化大鼠SIRT1/PGC1α通路及斑块稳定性的影响[J]. 中国老年学杂志, 2023, 43(12): 3009-3013.
[18] 刘婷, 于红红, 王文佳, 等. 基于PPARγ/LXRα/ABCG1通路探讨黄连解毒汤对泡沫细胞脂质蓄积的干预作用[J]. 时珍国医国药, 2023, 34(4): 838-842.
[19] Zhao, Z.W., Zhang, M., Wang, G., et al. (2021) Astragalin Retards Atherosclerosis by Pro-moting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages. Journal of Cardiovascular Pharmacology, 77, 217-227. [Google Scholar] [CrossRef
[20] Franceschelli, S., De Cecco, F., Pesce, M., et al. (2023) Hy-droxytyrosol Reduces Foam Cell Formation and Endothelial Inflammation Regulating the PPARγ/LXRα/ABCA1 Path-way. International Journal of Molecular Sciences, 24, Article 2057. [Google Scholar] [CrossRef] [PubMed]